FDCP
IBB icon

Foster Dykema Cabot & Partners’s iShares Biotechnology ETF IBB Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-128
Closed -$18.6K – 425
2024
Q3 		$18.6K Buy
+128
New +$18.5K ﹤0.01% 321

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Foster Dykema Cabot & Partners's IBB Position: Q4 2024 in Review

Foster Dykema Cabot & Partners sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 128 shares — an estimated $18.6K sold.

Foster Dykema Cabot & Partners first reported a position in IBB in Q3 2024 and held it in 1 quarter. The position peaked at $18.6K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • Foster Dykema Cabot & Partners reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • Foster Dykema Cabot & Partners sold 128 iShares Biotechnology ETF shares in Q4 2024, an estimated $18.6K.
  • Foster Dykema Cabot & Partners first reported a position in iShares Biotechnology ETF in Q3 2024 and held it in 1 quarter.
  • Foster Dykema Cabot & Partners's iShares Biotechnology ETF position peaked at $18.6K in Q3 2024.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Foster Dykema Cabot & Partners's 13F filing for Q4 2024, filed 13 Feb 2025.